MustGrow Biologics Corp.
MGROF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.09 | 0.29 | -0.09 | 0.28 |
| FCF Yield | -0.92% | -0.76% | -6.64% | -0.84% |
| EV / EBITDA | -13.50 | -43.14 | -34.51 | -389.09 |
| Quality | ||||
| ROIC | -69.34% | -32.17% | -38.10% | -42.67% |
| Gross Margin | 17.86% | 20.87% | 14.31% | 21.30% |
| Cash Conversion Ratio | 0.09 | 0.30 | 2.16 | 0.47 |
| Growth | ||||
| Revenue 3-Year CAGR | 1,960,750.14% | 1,651.60% | 840.23% | 294.58% |
| Free Cash Flow Growth | 3.94% | 90.81% | -518.95% | 47.60% |
| Safety | ||||
| Net Debt / EBITDA | 0.74 | -1.29 | -0.71 | 14.59 |
| Interest Coverage | -367.94 | -18.53 | -34.44 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.33 | 1.22 | 1.36 | 0.07 |
| Cash Conversion Cycle | 28.07 | 24.54 | 9.99 | -715.55 |